Your browser is no longer supported. Please, upgrade your browser.
GSK GlaxoSmithKline plc daily Stock Chart
GlaxoSmithKline plc
Index- P/E6.94 EPS (ttm)6.27 Insider Own- Shs Outstand2.44B Perf Week4.59%
Market Cap106.14B Forward P/E16.86 EPS next Y2.58 Insider Trans- Shs Float2.43B Perf Month2.96%
Income15.11B PEG0.91 EPS next Q- Inst Own10.10% Short Float0.15% Perf Quarter-4.89%
Sales36.47B P/S2.91 EPS this Y-48.70% Inst Trans-0.07% Short Ratio0.86 Perf Half Y1.74%
Book/sh4.40 P/B9.89 EPS next Y10.26% ROA20.00% Target Price45.33 Perf Year-4.34%
Cash/sh4.87 P/C8.93 EPS next 5Y7.60% ROE164.20% 52W Range40.13 - 48.45 Perf YTD4.64%
Dividend2.34 P/FCF- EPS past 5Y-12.10% ROI15.00% 52W High-10.20% Beta0.67
Dividend %5.38% Quick Ratio1.00 Sales past 5Y-4.10% Gross Margin68.20% 52W Low8.42% ATR0.59
Employees98702 Current Ratio1.30 Sales Q/Q5.90% Oper. Margin21.10% RSI (14)58.95 Volatility1.55% 1.09%
OptionableYes Debt/Eq2.52 EPS Q/Q-76.20% Profit Margin41.40% Rel Volume0.70 Prev Close43.44
ShortableYes LT Debt/Eq2.15 EarningsJul 29 Payout39.90% Avg Volume4.08M Price43.51
Recom2.80 SMA202.49% SMA501.29% SMA200-1.51% Volume2,863,286 Change0.16%
Jun-26-15Upgrade Liberum Sell → Hold
Jun-04-15Downgrade Morgan Stanley Overweight → Equal-Weight
May-20-15Resumed Citigroup Neutral
Apr-15-15Initiated Societe Generale Sell
Feb-19-15Reiterated Argus Buy $55 → $52
Aug-08-14Reiterated Argus Buy $65 → $55
Apr-23-14Upgrade Argus Hold → Buy
May-28-13Upgrade Deutsche Bank Hold → Buy
Jan-11-11Upgrade Jefferies Hold → Buy
Jun-02-10Upgrade Jefferies Hold → Buy
Feb-16-10Upgrade JP Morgan Underweight → Neutral $26
Jan-13-10Downgrade Credit Suisse Outperform → Underperform
Nov-24-09Initiated Leerink Swann Mkt Perform
Nov-16-09Initiated Deutsche Securities Hold
Nov-12-09Initiated Barclays Capital Equal Weight
Oct-23-09Downgrade Jefferies & Co Buy → Hold
Mar-17-09Initiated Credit Suisse Outperform
Jan-26-09Initiated Jefferies & Co Buy
Nov-14-08Downgrade UBS Buy → Neutral
Apr-18-08Downgrade JP Morgan Neutral → Underweight
Aug-03-15 12:55PM  AbbVie, Inc. Earnings Q2*, 2015
10:28AM  GSK rehires suspected China whistleblower at Financial Times
09:11AM  The Top 3 ETFs For Investing in Scotland at Investopedia
Jul-31-15 04:24PM  Ebola game changer?
02:18PM  There's more to Merck's Ebola vaccine than money at CNBC
01:00PM  A game changer for Ebola cure
11:29AM  After Merck success, work goes on with other Ebola vaccines
Jul-30-15 05:35PM  Brilinta? Brintellix? FDA warns of drug name mix-ups
11:32AM  GlaxoSmithKline (GSK) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
10:30AM  Glaxo Up on Q2 Earnings Beat, Revenues Rise, View Same - Analyst Blog
Jul-29-15 05:35PM  Advair revenue down again, but GSK looks to next-gen (and Zebulon) for replacement revenue at
04:25PM  Yelp and Twitter are big market movers
01:56PM  Exclusive: GSK faces new corruption allegations, this time in Romania Reuters
01:30PM  GSK Boosted by New Vaccines at The Wall Street Journal
12:27PM  4 Stocks, 4 trades: Gilead, Altria & more
12:06PM  GSK jumps 3% on strong EPS; Advair sales slump at CNBC
11:40AM  Glaxo Aims for Next Wave of Cancer Drugs After Missing First at Bloomberg
11:28AM  HIV/Aids treatments stand out as GSK promises 40-drug pipeline at Financial Times
10:00AM  GSK earnings relief
09:04AM  GSK flags up pipeline as HIV drugs help it beat profit forecasts
08:56AM  Glaxo Earnings Beat Estimates on AIDS Drugs, Cost Reductions at Bloomberg
08:37AM  Glaxo (GSK) Beats on Q2 Earnings, Revenues Up Y/Y - Tale of the Tape
08:30AM  Drugmaker GSK sees earnings growth returning in 2016
08:16AM  GSK sees drop in earnings after asset swap with Novartis
07:37AM  GlaxoSmithKline second-quarter beats despite Advair hit, lower margins
07:10AM  GlaxoSmithKline Q2 beats despite Advair hit, lower margins
Jul-28-15 06:52PM  Google, Amazon And Microsoft Curb Spending To Boost Profits
04:34PM  Gilead Lifts Sales View As Hep C Drugs Top
03:52PM  Eurozone Business Activity Seems Undeterred by Greek Crisis
Jul-27-15 06:25PM  Cramer's shopping list for a pullback
03:50PM  Will Headwinds Weigh on Glaxo's (GSK) Earnings in Q2? - Analyst Blog
03:23PM  3 Questions GlaxoSmithKline Investors Want Answered on July 29 at Motley Fool
Jul-25-15 02:52AM  Global Contrarian Sees Value All Around at
Jul-24-15 04:24PM  First Malaria vaccine
01:14PM  30 year fight: Malaria vaccine approval
12:59PM  GSK: dose of reality at Financial Times
11:50AM  Worlds first malaria vaccine, from GlaxoSmithKline, wins approval from EU at Fortune
11:40AM  How effective is new malaria vaccine?
10:24AM  EU regulator recommends 1st license for malaria vaccine
07:10AM  Malaria vaccine moves toward approval with Lexington biotech's help at
07:03AM  World's first malaria vaccine gets regulatory go-ahead, faces WHO review Reuters
04:22AM  World's first malaria vaccine gets go-ahead from EU regulators Reuters
04:13AM  UPDATE 1-World's first malaria vaccine gets go-ahead from EU regulators Reuters
01:00AM  World's first malaria vaccine gets green light from Europe at Financial Times
01:00AM  Glaxo's Malaria Vaccine Clears Final Scientific Hurdle at The Wall Street Journal
01:00AM  First Malaria Vaccine Gains Recommendation After 28-Year Odyssey at Bloomberg
01:00AM  First Malaria Vaccine Gains Recommendation After 28-Year Odyssey
Jul-22-15 01:01PM  Doctors Are Optimistic About Axovant's Experimental Alzheimer's Drug at Forbes
10:43AM  Novartis (NVS) Beats on Earnings in Q2, 2015 View Retained - Analyst Blog
Jul-21-15 03:00PM  GlaxoSmithKline lawsuit claims software company breached copyright agreement at
01:37PM  Novartis (NVS) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
01:15PM  Novartis' Mixed Q2: Sandoz Booms, Alcon Struggles at Investor's Business Daily
09:01AM  Sanofi cholesterol drug, GSK malaria shot may get EU okay Friday Reuters
Jul-20-15 10:03PM  Novartis sees 20 percent income fall due to strong dollar AFP
02:10PM  GSK slips from the No. 1 social media spot in Big Pharma at
02:00PM  Largest Trial for AIDS Treatment Planned After French Teen's Remission
01:14PM  Catabasis Pharmaceuticals Shares Could Double at
07:02AM  Exelixis Drug Slows Kidney Cancer In New Chance For Embattled Biotech at Forbes
Jul-19-15 06:42AM  Pfizer ranked top foreign research partner for UK academics at Financial Times
Jul-17-15 02:27PM  Why Shares in Axovant Sciences Are Soaring 20% Higher Today at Motley Fool
Jul-16-15 08:00AM  GSK begins shipping 2015-16 US flu vaccines with focus on customer needs, volume, and speed PR Newswire
Jul-15-15 07:21PM  Drug trial hints at possible way to tackle Alzheimer's at Financial Times
06:15PM  Cramer: Receptos perfect fit for Celgene
Jul-14-15 05:18PM  Tweedy Browne Global Value Adds to Eight Stakes in Portfolio
Jul-13-15 07:03PM  UK's new biomedical research centre teams up with industry at Financial Times
Jul-09-15 02:00AM  Success at Glaxo's HIV Unit May Mean Having to Call It Quits
Jul-07-15 08:57AM  Regulators issue competing proposals for audit partner disclosure at MarketWatch
Jul-06-15 04:15PM  Adaptimmune's IND Application for MAGE-A10 Accepted - Analyst Blog
Jul-05-15 12:47PM  European pharma groups paid $1.5bn to US doctors in 2015 at Financial Times
Jul-02-15 09:00AM  GSK's Viiv arm agrees China tie-up to produce HIV drugs at Financial Times
03:00AM  ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries PR Newswire
Jul-01-15 02:15PM  GlaxoSmithKline to open $95M nonprofit cell research center in Seattle at
08:02AM  Can Hepatitis B Be A Blockbuster Bug? at Investor's Business Daily
05:22AM  Drug companies grilled over Aust pricing AAP
Jun-30-15 09:52PM  Inquiry asks about drug price 'rip-off' AAP
05:31PM  Big pharma to be grilled on tax avoidance AAP
05:26PM  Pharma giant GlaxoSmithKline reveals $175K paid to hundreds of Triangle doctors at
01:47PM  Glaxo Paid Doctors $15 Million Before Pledge to End Fees in 2016 at Bloomberg
Jun-29-15 09:43AM  3 Reasons I Have Little Confidence in GlaxoSmithKline's Dividend at Motley Fool
Jun-26-15 06:02PM  Dow 30 Stock Roundup: Nike Beats Estimates, Verizon Closes AOL Buy - Analyst Blog
07:48AM  GlaxoSmithKline upgraded by Liberum
Jun-25-15 04:35PM  Glaxo, Pfizer Meningitis B Vaccines Get ACIP's Category B - Analyst Blog
11:16AM  Parexel to cut 850 jobs; Durham impact not immediately known at
Jun-24-15 01:33PM  Eurozone Business Activity Is at Its Highest Level in 4 Years
01:32PM  U.S. CDC committee recommends physicians make individual decisions on the use of meningococcal group B vaccines PR Newswire
Jun-23-15 04:40PM  Pfizer to Buy Two Meningitis Vaccines from Glaxo for $130M - Analyst Blog
03:51PM  GSK Vaccinates Pfizer to Gain Novartis - Video Blog
Jun-22-15 05:41PM  Pfizer to buy two vaccines from Glaxo AAP
09:28AM  GlaxoSmithKline (GSK) Stock Gains Following Meningitis Vaccines Sale to Pfizer at TheStreet
08:35AM  Pfizer to Acquire Two Meningitis Vaccines at The Wall Street Journal
07:45AM  GSK sells two vaccines to Pfizer to ease competition concerns Reuters
05:40AM  Gardasil-9 Effectively Stops 90 Percent Of Cancers Caused By HPV In Girls and Boys at Forbes
Jun-18-15 11:02PM  British Investigator Says Chinese Officials Tried to Force Confession at The Wall Street Journal
02:21PM  U.K. Investigator Says Chinese Officials Tried to Force Confession at The Wall Street Journal
09:37AM  Chardan: Sell Axovant Sciences, RVT-101 Market Pricing Is 'Highly Irrational'
08:24AM  Slow Sales Uptake For Brintellix Show The Challenges Facing New Depression Drugs at Forbes
06:30AM  UK investigator says Chinese officials mistreated him to get GSK confession Reuters
Jun-17-15 06:00PM  Cramer: How to play today's Fed meeting
02:10PM  GlaxoSmithKline dropping $95M to create research institute at
08:01AM  Photographer Documents Deadly Brain Infection As CDC Considers Vaccine at Forbes
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, including respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas. The company's wellness products include Panadol and Panadol Cold & Flu for headache, joint pain, fever, and cold symptoms; ENO and Tums that are immediate relief antacids; and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to smoking reduction and cessation. Its oral health products comprise Sensodyne to treat and prevent dental sensitivity and acid erosion; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; and Aquafresh for the prevention of caries, gum disease, and bad breath. The company's nutrition products include Horlicks, a nutritional beverages and food; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, as well as Zovirax and Abreva to treat and prevent the onset of cold sores. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerMay 11Buy14.00365,1065,111,484365,106May 13 12:36 PM
GLAXOSMITHKLINE PLC10% OwnerMar 02Buy18.0692,6741,673,69231,673,853Mar 02 03:45 PM
GLAXOSMITHKLINE PLC10% OwnerAug 11Buy22.66172,6513,912,27230,748,723Aug 11 04:55 PM